Abstract
The implementation of Whole-Genome Sequencing (WGS) as a clinical test has been a source of speculation, anticipation, and anecdotes for many years. The first clinical (CLIA-certified, CAP-accredited) laboratory to offer this test launched the service in 2009, and despite several significant challenges that still surround the offering and use of WGS for clinical applications, it has largely been embraced by an enthusiastic community of physicians and clinical laboratorians. In this chapter, we discuss the many considerations, caveats, challenges, and opportunities that must be addressed when implementing clinical WGS. Approaches to this implementation are also discussed. The chapter is organized into sections on test definition, staffing and training, infrastructure, validations, and interpretation and reporting considerations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gene tests. http://www.genetests.org. October 2013.
Clinical Laboratory Standards Institute (CLSI). Multiple standards publications relating to laboratory process and sequencing. http://www.clsi.org/standards/.
College of American Pathologists (CAP). Molecular pathology checklist. 2013:1–67.
Chen B, Gagnon MC, Shahangian S, Anderson NL, Howerton DA, Boone DJ. Good laboratory practices for molecular genetic testing for heritable diseases and conditions: Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention. MMWR Recomm Rep. 2009;58(No. RR-6):1–37.
Gargis AS, Kalman L, Berry MW, Bick DP, Dimmock DP, Hambuch T, et al. Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol. 2012;30(11):1033–6.
Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15:565–74.
Group AMPWGAW. The Association for Molecular Pathology’s approach to supporting a global agenda to embrace personalized genomic medicine. J Mol Diagn. 2011;13(3):249–51.
Schrijver I, Aziz N, Farkas DH, Furtado M, Gonzalez AF, Greiner TC, et al. Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. J Mol Diagn. 2012;14(6):525–40.
Rehm HL, Bale SJ, Bayrak-Toydemir P, Berg JS, Brown KK, Deignan JL, Friez MJ, Funke BH, Hegde MR, Lyon E, Working Group of the American College of Medical Genetics and Genomics Laboratory Quality Assurance Committee. 2013:1–15.
Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, et al. Exome sequencing identifies the cause of a Mendelian disorder. Nat Genet. 2010;42(1):30–5.
Dinwiddie DL, Kingsmore SF, Caracciolo S, Rossi G, Moratto D, Mazza C, et al. Combined DOCK8 and CLEC7A mutations causing immunodeficiency in 3 brothers with diarrhea, eczema, and infections. J Allergy Clin Immunol. 2013;131(2):594–7.
Worthey EA, Mayer AN, Syverson GD, Helbling D, Bonacci BB, Decker B, et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med. 2011;13(3):255–62.
Saunders CJ, Miller NA, Soden SE, Dinwiddie DL, Noll A, Alnadi NA, et al. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med. 2012;4:154.
Flicek P, Birney E. Sense from sequence reads: methods for alignment and assembly. Nat Methods. 2009;6(11 Suppl):S6–12.
Li H, Homer N. A survey of sequence alignment algorithms for next-generation sequencing. Brief Bioinform. 2010;11:473–83.
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078–9.
Nielsen R, Paul JS, Albrechtsen A, Song YS. Genotype and SNP calling from next-generation sequencing data. Nat Rev Genet. 2011;12(6):443–51.
Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073–81.
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Aondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7:248–9.
Maddalena A, Bale S, Das S, Grody W, Richards S, Committee ALQA. Technical standards and guidelines: molecular genetic testing for ultra-rare disorders. Genet Med. 2005;7:571–83.
ALPCW Group. ACMG recommendations for standards for interpretation of sequence variations. Genet Med. 2000;2:302–3.
Antonarakis SE, The Nomenclature Working Group. Recommendations for a nomenclature system for human gene mutations. Hum Mutat. 1998;11:1–3.
den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat. 2000;15:7–12.
Online Mendelian Inheritance in Man, OMIM®. Baltimore, MD: McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University; 2013. http://omim.org/.
Jones SJ, Laskin J, Li YY, Griffith OL, An J, Bilenky M, et al. Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors. Genome Biol. 2010;11(8):R82.
Mwenifumbo JC, Marra MA. Cancer genome-sequencing study design. Nat Rev Genet. 2013;14(5):321–32.
International Standards for Cytogenomic Arrays Consortium. 2013. http://www.iscaconsortium.org.
Grody WW, Thompson BH, Gregg AR, Bean LH, Monahan KG, Schneider A, Leb RV. ACMG position statement on prenatal/preconception expanded carrier screening. Genet Med. 2013;15:482–3.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Glossary
- Proband 
-
Affected individual on whom testing is being performed.
- Mendelian condition 
-
A condition that is caused by variants within a single gene and that can be passed to offspring in an autosomal dominant or autosomal recessive pattern.
- Disease prevalence 
-
Proportion of a population to have a condition.
- Allele frequency 
-
Proportion of a particular allele among all alleles for a gene.
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hambuch, T.M., Mead, CL. (2015). Implementation of Genome Sequencing Assays. In: Netto, G., Schrijver, I. (eds) Genomic Applications in Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0727-4_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0727-4_17
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0726-7
Online ISBN: 978-1-4939-0727-4
eBook Packages: MedicineMedicine (R0)